Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Bioentrepreneur
  • Published:

Research biotech patenting 2014

Nature Biotechnology volume 33, page 684 (2015)Cite this article

Subjects

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Research biotech patent trends, 2010–2014.
Figure 2: Application dates of research patents issued in 2014.

Author information

Authors and Affiliations

  1. Brady Huggett is business editor at Nature Biotechnology.,

    Brady Huggett

  2. Kathryn Paisner is director of research and analytics at IP Checkups Inc., Berkeley, California, USA.,

    Kathryn Paisner

Authors
  1. Brady Huggett
    View author publications

    Search author on:PubMed Google Scholar

  2. Kathryn Paisner
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Kathryn Paisner.

Ethics declarations

Competing interests

K.P. is employed by IP Checkups Inc.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huggett, B., Paisner, K. Research biotech patenting 2014. Nat Biotechnol 33, 684 (2015). https://doi.org/10.1038/nbt.3288

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt.3288

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research